| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Esperion Therapeutics Inc (F: 0ET)
0ET Technical Analysis
4
| As on 20th Nov 2024 0ET STOCK Price closed @ 2.38 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.61 & Strong Buy for SHORT-TERM with Stoploss of 1.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
0ETSTOCK Price
| Open | 2.09 | Change | Price | % |
| High | 2.38 | 1 Day | 0.55 | 30.05 |
| Low | 2.09 | 1 Week | 0.41 | 20.81 |
| Close | 2.38 | 1 Month | 0.70 | 41.67 |
| Volume | 800 | 1 Year | 1.10 | 85.94 |
| 52 Week High 2.99 | 52 Week Low 0.67 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| 0ET Daily Charts |
0ET Intraday Charts |
Whats New @ Bazaartrend |
0ET Free Analysis |
|
|
0ET Important Levels Intraday
| RESISTANCE | 2.94 |
| RESISTANCE | 2.76 |
| RESISTANCE | 2.65 |
| RESISTANCE | 2.54 |
| SUPPORT | 2.22 |
| SUPPORT | 2.11 |
| SUPPORT | 2.00 |
| SUPPORT | 1.82 |
0ET Forecast November 2024
| 4th UP Forecast | 3.29 |
| 3rd UP Forecast | 3 |
| 2nd UP Forecast | 2.82 |
| 1st UP Forecast | 2.64 |
| 1st DOWN Forecast | 2.12 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.76 |
| 4th DOWN Forecast | 1.47 |
0ET Weekly Forecast
| 4th UP Forecast | 2.55 |
| 3rd UP Forecast | 2.50 |
| 2nd UP Forecast | 2.46 |
| 1st UP Forecast | 2.43 |
| 1st DOWN Forecast | 2.33 |
| 2nd DOWN Forecast | 2.30 |
| 3rd DOWN Forecast | 2.26 |
| 4th DOWN Forecast | 2.21 |
0ET Forecast2024
| 4th UP Forecast | 6.85 |
| 3rd UP Forecast | 5.42 |
| 2nd UP Forecast | 4.53 |
| 1st UP Forecast | 3.64 |
| 1st DOWN Forecast | 1.12 |
| 2nd DOWN Forecast | 0.23 |
| 3rd DOWN Forecast | -0.66 |
| 4th DOWN Forecast | -2.09 |
Esperion Therapeutics Inc ( F Germany Symbol : 0ET )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
0ET Business Profile
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Address: 3891 Ranchero Drive, Ann Arbor, MI, United States, 48108
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service